DiaMedica Therapeutics Cash Flow Statement (2017-2026) | DMAC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-3.45M	-3.25M	-3.51M	-3.36M	-3.06M	-3.75M	-5.27M	-4.48M	-4.47M	-5.16M	-5.15M	-5.12M	-6.27M	-7.90M	-7.71M	-7.70M	-8.62M	-3.80M	-10.04M	-10.14M
Depreciation and Depletion (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.00M	0.02M	0.01M	0.01M	0.01M
Share-based Compensation (Quarter)	0.30M	0.30M	0.31M	0.36M	0.42M	0.41M	0.42M	0.38M	0.42M	0.46M	0.49M	0.44M	0.56M	0.59M	0.87M	0.77M	1.02M	1.19M	0.82M	1.12M
Gains from Investment Securities (Quarter)
Cash from Operations (Quarter)	-3.05M	-2.80M	-3.89M	-2.50M	-2.36M	-2.77M	-5.09M	-5.03M	-4.80M	-3.81M	-6.65M	-4.52M	-4.47M	-6.43M	-7.15M	-7.60M	-6.55M	-7.76M	-9.08M	-8.10M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.00M	0.02M	0.01M	0.01M	0.01M
Change in Working Capital
Change in Receivables (Quarter)	0.09M	0.03M	0.04M	-0.08M	-0.01M	0.01M	-0.03M	0.13M	0.12M	0.06M	0.03M	-0.01M	-0.10M	-0.05M	0.02M	-0.09M	0.10M	-0.00M	0.04M	-0.06M
Change in Account Payables (Quarter)	0.46M	-0.19M	-0.08M	0.19M	0.24M	-0.13M	1.05M	-0.92M	0.01M	0.06M	-0.21M	0.04M	0.41M	-0.23M	0.57M	-0.25M	0.66M	-0.45M	1.82M	-0.48M
Change in Accured Expenses (Quarter)	-0.29M	0.09M	-0.02M	-0.09M	-0.27M	0.74M	-0.42M	0.04M	0.20M	0.53M	0.02M	0.39M	0.78M	1.30M	-1.31M	-0.33M	0.47M	0.28M	-1.23M	1.30M
Investing Activities
Capital Expenditures (Quarter)	0.00M	0.01M		0.01M	0.04M	0.03M	0.01M	0.00M	0.01M	0.00M	0.01M		0.01M	0.01M	0.01M	0.01M	0.02M	0.01M	0.01M	0.00M
Sales of Property, Plant and Equipment (Quarter)
Change in Acquisitions & Divestments (Quarter)	9.67M	13.39M	15.59M	16.66M	10.50M	14.54M	12.34M	14.79M	13.00M	11.00M	14.00M	13.00M	16.00M	16.00M	13.50M	18.47M	9.10M	16.05M	16.79M	13.00M
Cash from Investing Activities (Quarter)	-12.83M	-8.69M	2.21M	2.53M	2.07M	4.72M	2.51M	-28.13M	1.20M	6.12M	4.21M	4.74M	-5.58M	5.21M	6.62M	8.96M	-25.77M	8.00M	-2.11M	8.24M
Financing Activities
Other financing activities (Quarter)												0.01M	0.13M	0.12M	0.09M	0.16M	0.47M	0.28M	0.42M	0.14M
Change in Capital Stock
Shares Issued (Quarter)	1.96M	1.90M	2.16M	2.62M	2.78M	2.78M	2.77M	3.64M	3.70M	3.87M	4.26M	4.86M	4.63M	4.69M	5.05M	6.69M	7.32M	6.86M	6.41M	8.18M
Net Equity Issued and Repurchased (Quarter)	29.87M	-0.02M							-0.00M								31.53M	11.76M
Misc.
Cash from Financing Activities (Quarter)	29.86M	-0.02M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	36.85M	-0.01M	-0.00M	-0.00M	11.75M	0.12M	0.12M	0.09M	0.16M	31.53M	12.09M	0.42M	0.13M
Change in Cash (Quarter)	13.99M	-11.51M	-1.68M	0.03M	-0.29M	1.96M	-2.58M	3.69M	-3.61M	2.31M	-2.45M	11.97M	-9.93M	-1.11M	-0.44M	1.52M	-0.78M	12.32M	-10.78M	0.26M
Free Cash Flow (Quarter)	-3.05M	-2.81M	-3.89M	-2.50M	-2.40M	-2.80M	-5.10M	-5.03M	-4.81M	-3.81M	-6.66M	-4.52M	-4.48M	-6.44M	-7.16M	-7.60M	-6.57M	-7.77M	-9.09M	-8.10M
Net Cash Flow (Quarter)	13.99M	-11.51M	-1.68M	0.03M	-0.29M	1.96M	-2.58M	3.69M	-3.61M	2.31M	-2.45M	11.97M	-9.93M	-1.11M	-0.44M	1.52M	-0.79M	12.32M	-10.78M	0.28M

Research Tools

Datasets

Plans

Developers

DiaMedica Therapeutics Cash Flow Statement (2017-2026) | DMAC

Research Tools

Datasets

Plans

Developers

DiaMedica Therapeutics Cash Flow Statement (2017-2026) | DMAC

Create an account

Sign In

Reset Password